Prophylactic Mastectomy: An Appraisal-Reference-Cited by-同舟云学术

Prophylactic Mastectomy: An Appraisal

Published:2013-02 Issue:2 Volume:79 Page:205-212
ISSN:0003-1348
Container-title:The American Surgeon
language:en
Short-container-title:The American Surgeon

Author:

Zagouri Flora¹,Chrysikos Dimosthenis T.¹,Sergentanis Theodoros N.¹,Giannakopoulou Georgia¹,Zografos Constantine G.¹,Papadimitriou Christos A.¹,Zografos George C.¹

Affiliation:

1. From the Breast Unit, 1st Department of Propaedeutic Surgery, Hippokratio Hospital, University of Athens, Athens, Greece

Abstract

The main indication of prophylactic mastectomy pertains to BRCA1 or BRCA2 mutation carriers. Prophylactic mastectomy includes the simple method and the subcutaneous method. Both methods can be followed by breast plastic reconstruction either at the same time or later. This review examines key issues regarding prophylactic mastectomy: the selection of patients, its effectiveness, its limitations, convergence/divergence in existing guidelines, and future perspectives.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/000313481307900233

Reference101 articles.

1. The Prevention of Hereditary Breast Cancer

2. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction

3. Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis

4. American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

5. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery;Familial Cancer;2016-02-13